RU2008103151A - Термически обработанные продукты какао, которые могут быть использованы для улучшения состояния сосудов - Google Patents

Термически обработанные продукты какао, которые могут быть использованы для улучшения состояния сосудов Download PDF

Info

Publication number
RU2008103151A
RU2008103151A RU2008103151/13A RU2008103151A RU2008103151A RU 2008103151 A RU2008103151 A RU 2008103151A RU 2008103151/13 A RU2008103151/13 A RU 2008103151/13A RU 2008103151 A RU2008103151 A RU 2008103151A RU 2008103151 A RU2008103151 A RU 2008103151A
Authority
RU
Russia
Prior art keywords
cocoa
epicatechin
catechin
disease
polyphenols
Prior art date
Application number
RU2008103151/13A
Other languages
English (en)
Russian (ru)
Inventor
Гарольд Х. ШМИТЦ (US)
Гарольд Х. ШМИТЦ
Кэтрин Л. КВИК-УРИБЕ (US)
Кэтрин Л. КВИК-УРИБЕ
Джон Ф. ХАММЕРСТОУН (US)
Джон Ф. ХАММЕРСТОУН
Марк А. КЕЛМ (US)
Марк А. КЕЛМ
Ребекка Дж. РОББИНС (US)
Ребекка Дж. РОББИНС
Original Assignee
Марс, Инкорпорейтед (Us)
Марс, Инкорпорейтед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Марс, Инкорпорейтед (Us), Марс, Инкорпорейтед filed Critical Марс, Инкорпорейтед (Us)
Publication of RU2008103151A publication Critical patent/RU2008103151A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5777—Theobroma, e.g. cocao or cocoa
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/0003—Processes of manufacture not relating to composition or compounding ingredients
    • A23G1/0006—Processes specially adapted for manufacture or treatment of cocoa or cocoa products
    • A23G1/0009—Manufacture or treatment of liquids, creams, pastes, granules, shreds or powders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/56—Liquid products; Solid products in the form of powders, flakes or granules for making liquid products, e.g. for making chocolate milk, drinks and the products for their preparation, pastes for spreading or milk crumb
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
RU2008103151/13A 2005-06-29 2006-06-29 Термически обработанные продукты какао, которые могут быть использованы для улучшения состояния сосудов RU2008103151A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69536105P 2005-06-29 2005-06-29
US60/695,361 2005-06-29

Publications (1)

Publication Number Publication Date
RU2008103151A true RU2008103151A (ru) 2009-08-10

Family

ID=37596059

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008103151/13A RU2008103151A (ru) 2005-06-29 2006-06-29 Термически обработанные продукты какао, которые могут быть использованы для улучшения состояния сосудов

Country Status (9)

Country Link
EP (1) EP1896442A2 (fr)
JP (1) JP2009501161A (fr)
CN (1) CN101228148A (fr)
AU (1) AU2006263666A1 (fr)
CA (1) CA2611849A1 (fr)
IL (1) IL188073A0 (fr)
MX (1) MX2007016272A (fr)
RU (1) RU2008103151A (fr)
WO (1) WO2007002851A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3744324A1 (fr) 2006-06-15 2020-12-02 Mars Incorporated Procédés et compositions pour améliorer la fonction cognitive
EP2068941A4 (fr) * 2006-07-21 2009-09-30 Mars Inc Amélioration des concentrations ou de l'activité de l'arginase
US8372456B2 (en) 2006-11-17 2013-02-12 Barry Callebaut Ag Method for producing a soluble cocoa product from cocoa powder
WO2009118418A1 (fr) * 2008-03-28 2009-10-01 Barry Callebaut Ag Composition de cacao
US8609174B2 (en) 2006-11-17 2013-12-17 Barry Callebaut Ag Method for producing a soluble cocoa product from cocoa powder
GB0719544D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and use thereof
GB0719545D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719542D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract
GB0724716D0 (en) 2007-12-19 2008-01-30 Barry Callebaut Ag Process
GB0801401D0 (en) * 2008-01-25 2008-03-05 Barry Callebaut Ag Composition
WO2010092941A1 (fr) * 2009-02-16 2010-08-19 株式会社 ブルボン Composition ayant une activité de vasodilatation, son procédé de production et son utilisation
CN102984953A (zh) * 2010-03-05 2013-03-20 马斯公司 具有可可提取物的可口的饮料及组合物
ITRM20110600A1 (it) * 2011-11-14 2013-05-15 Univ Roma Uso di una miscela di catechina ed epicatechina per l'inibizione della funzione piastrinica
JP5868787B2 (ja) * 2012-06-08 2016-02-24 長谷川香料株式会社 カカオ風味飲食品用呈味改善剤
WO2015102394A1 (fr) 2014-01-02 2015-07-09 Lg Electronics Inc. Dispositif d'émission de diffusion et son procédé de fonctionnement, et dispositif de réception de diffusion et son procédé de fonctionnement
KR20170012485A (ko) * 2014-05-30 2017-02-02 샤클리 코포레이션 샤도네이 포도 종자 추출물
JP6772064B2 (ja) * 2014-10-17 2020-10-21 株式会社明治 ポリフェノール含有機能性経口組成物
CN105994863A (zh) * 2016-05-12 2016-10-12 昆明杏梓生物科技有限公司 一种含虾青素的巧克力制品及其制备方法与应用
CN105997984B (zh) * 2016-05-13 2021-07-02 合肥迈可罗生物工程有限公司 表儿茶素及其衍生物在制备降血脂药物中的应用
WO2017208058A1 (fr) * 2016-06-03 2017-12-07 Casaluker S.A. Produits à base de poudre de cacao à haute teneur en polyphénols, utilisations et procédés de fabrication associés
JP6675429B2 (ja) * 2018-02-28 2020-04-01 長谷川香料株式会社 飲食品用呈味改善剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312753B1 (en) * 1996-09-06 2001-11-06 Mars, Incorporated Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses

Also Published As

Publication number Publication date
CN101228148A (zh) 2008-07-23
JP2009501161A (ja) 2009-01-15
WO2007002851A2 (fr) 2007-01-04
MX2007016272A (es) 2008-03-05
CA2611849A1 (fr) 2007-01-04
WO2007002851A3 (fr) 2007-03-01
AU2006263666A1 (en) 2007-01-04
EP1896442A2 (fr) 2008-03-12
IL188073A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
Hu et al. Physicochemical properties and antioxidant capacity of raw, roasted and puffed cacao beans
Di Mattia et al. Effect of different conching processes on procyanidin content and antioxidant properties of chocolate
Elwers et al. Differences between the content of phenolic compounds in Criollo, Forastero and Trinitario cocoa seed (Theobroma cacao L.)
Oracz et al. The content of polyphenolic compounds in cocoa beans (Theobroma cacao L.), depending on variety, growing region, and processing operations: A review
Ye et al. Interactions of black and green tea polyphenols with whole milk
Guyot et al. Reversed-phase HPLC following thiolysis for quantitative estimation and characterization of the four main classes of phenolic compounds in different tissue zones of a French cider apple variety (Malus domestica var. Kermerrien)
Ferruzzi et al. Analysis of catechins from milk–tea beverages by enzyme assisted extraction followed by high performance liquid chromatography
Kothe et al. Temperature influences epimerization and composition of flavanol monomers, dimers and trimers during cocoa bean roasting
Liu et al. Effect of laboratory-scale decoction on the antioxidative activity of Zhenjiang Aromatic Vinegar: The contribution of melanoidins
JP2010535256A (ja) ポリフェノールを含む組成物
CN105685316B (zh) 一种藤茶菊花复合饮料及其制备方法
KR20090024157A (ko) 프로안토시아니딘 함유 차 음료
JP2002027957A (ja) 植物ポリフェノール含有液体組成物
Misnawi et al. Changes in polyphenol ability to produce astringency during roasting of cocoa liquor
WO2010092941A1 (fr) Composition ayant une activité de vasodilatation, son procédé de production et son utilisation
Tschiersch et al. Degree of hydrolysis of some vegetable proteins used as fining agents and its influence on polyphenol removal from red wine
WO2007002851A3 (fr) Produits a base de cacao thermiquement traites utilises dans l'amelioration de la sante vasculaire
Zorenc et al. Are processed bilberry products a good source of phenolics?
JP2006129757A (ja) 苦味やえぐ味を低減した緑茶抽出物、及び該抽出物を含有する飲食品
PT1605769E (pt) Fabrico do chá
JP2000060427A (ja) 健康紅茶飲料
Odžaković et al. Bioactive components and antioxidant, antiproliferative, and antihyperglycemic activities of wild cornelian cherry (Cornus mas L.)
JP2002338464A (ja) 筋肉萎縮抑制剤
Quiñones et al. Mechanisms for antihypertensive effect of CocoanOX, a polyphenol-rich cocoa powder, in spontaneously hypertensive rats
US20070003640A1 (en) Process for controlling the isomerization of (-)-epicatechin and (+)-catechin in edible products

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20120627